Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Takeda Pharmaceutical.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Takeda Pharmaceutical.

Recommendation Trends

Rating	Dec '22	Jan '23	Feb '23	Mar '23	Apr '23	May '23
Strong Buy	0	0	0	1	1	0
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	2	2	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ken Cacciatore TD Cowen	TD Cowen	Buy Maintains $30 → $20	Buy	Maintains	$30 → $20	+31.75%	May 16, 2023
Ken Cacciatore TD Cowen	TD Cowen	Buy Maintains $24 → $30	Buy	Maintains	$24 → $30	+97.63%	Apr 4, 2023
Koichi Mamegano B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $20	Hold → Strong Buy	Upgrades	$20	+31.75%	Mar 16, 2023
Ken Cacciatore Cowen & Co.	Cowen & Co.	Hold → Buy Upgrades $21 → $24	Hold → Buy	Upgrades	$21 → $24	+58.10%	Jul 19, 2022
Ken Cacciatore Cowen & Co.	Cowen & Co.	Hold Initiates $20	Hold	Initiates	$20	+28.46%	Nov 1, 2019

More Analyst Ratings

Financial Forecast

Revenue This Year

4,627.60B

Increased by 8.53%

from 4,263.76B

Revenue Next Year

4,621.69B

Decreased by -0.13%

from 4,627.60B

EPS This Year

88.27

Decreased by -3.16%

from 91.16

EPS Next Year

148.22

Increased by 67.91%

from 88.27

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	3,291.19B	3,197.81B	3,569.01B	4,027.48B	4,263.76B	4,627.60B	4,621.69B	4,679.48B
Revenue Growth	56.93%	-2.84%	11.61%	12.85%	5.87%	8.53%	-0.13%	1.25%
EPS	28.25	238.96	145.87	201.94	91.16	88.27	148.22	181.79
EPS Growth	-79.80%	745.88%	-38.96%	38.44%	-54.86%	-3.16%	67.91%	22.65%
Forward PE	-	-	-	-	-	24.62	14.66	11.96
No. Analysts	-	-	-	-	-	20	20	17

Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	4.9T	5.0T	5.2T
Avg	4.6T	4.6T	4.7T
Low	4.3T	4.3T	4.2T

Revenue Growth

Revenue Growth	2025	2026	2027
High	15.4%	8.6%	13.1%
Avg	8.5%	-0.1%	1.3%
Low	-0.0%	-6.1%	-8.2%

EPS Forecast

EPS	2025	2026	2027
High	110.46	253.03	294.72
Avg	88.27	148.22	181.79
Low	74.04	61.74	61.74

EPS Growth

EPS Growth	2025	2026	2027
High	21.2%	186.6%	98.8%
Avg	-3.2%	67.9%	22.6%
Low	-18.8%	-30.1%	-58.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.